TY  - RPRT
TI  - CACNA1C as a Prognostic Biomarker and Therapeutic Target in High-Grade Serous Ovarian Cancer: Clinical Validation and Molecular Dynamics of Nifedipine Blockade
AU  - HAMMAD, M.
AU  - Wu, K.
AU  - Saad, E.
AU  - Aboody, K.
AU  - Chang, C.-e.
PY  - 2026
DO  - 10.64898/2026.04.19.719516
UR  - https://www.biorxiv.org/content/10.64898/2026.04.19.719516v1
ID  - 10.64898/2026.04.19.719516
ER  -